ATRI Atrion Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: ATRI

Price (delayed)

$398.97

Market cap

$702.12M

P/E Ratio

36.2

Dividend/share

$8.75

EPS

$11.02

Enterprise value

$698.56M

Atrion Corporation is a leading supplier of medical devices and components to niche markets in the health care and medical industry. Atrion's proprietary products, ranging from cardiovascular and ophthalmology products ...

Highlights
Atrion's debt has shrunk by 100% QoQ
Atrion's quick ratio has increased by 27% from the previous quarter but it has decreased by 16% YoY
ATRI's net income is down by 45% year-on-year and by 9% since the previous quarter
The EPS has decreased by 44% YoY and by 9% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.atrioncorp.com
Peers: COO STAA TFX VUZI

Key stats

What are the main financial stats of ATRI
Market
Shares outstanding
1.76M
Market cap
$702.12M
Enterprise value
$698.56M
Valuations
Price to earnings (P/E)
36.2
Price to book (P/B)
2.89
Price to sales (P/S)
4.15
EV/EBIT
31.01
EV/EBITDA
18.57
EV/Sales
4.13
Earnings
Revenue
$169.33M
EBIT
$22.52M
EBITDA
$37.62M
Free cash flow
-$2.31M
Per share
EPS
$11.02
Free cash flow per share
-$1.31
Book value per share
$138.02
Revenue per share
$96.15
TBVPS
$141.98
Balance sheet
Total assets
$260.83M
Total liabilities
$17.94M
Debt
$0
Equity
$242.89M
Working capital
$102.14M
Liquidity
Debt to equity
0
Current ratio
9.09
Quick ratio
2.32
Net debt/EBITDA
-0.09
Margins
EBITDA margin
22.2%
Gross margin
36.8%
Net margin
11.5%
Operating margin
13.3%
Efficiency
Return on assets
7.4%
Return on equity
8.1%
Return on invested capital
9.5%
Return on capital employed
9.1%
Return on sales
13.3%
Dividend
Dividend yield
2.19%
DPS
$8.75
Payout ratio
79.4%

ATRI stock price

How has the Atrion stock price performed over time
Intraday
-5.95%
1 week
3.44%
1 month
-8.7%
1 year
-38%
YTD
5.33%
QTD
-13.93%

Financial performance

How have Atrion's revenue and profit performed over time
Revenue
$169.33M
Gross profit
$62.39M
Operating income
$22.58M
Net income
$19.41M
Gross margin
36.8%
Net margin
11.5%
ATRI's net income is down by 45% year-on-year and by 9% since the previous quarter
Atrion's operating income has decreased by 43% YoY and by 9% from the previous quarter
Atrion's net margin has decreased by 40% YoY and by 9% QoQ
The operating margin has contracted by 38% YoY and by 10% from the previous quarter

Growth

What is Atrion's growth rate over time

Valuation

What is Atrion stock price valuation
ATRI P/E details
P/E
36.2
P/B
2.89
P/S
4.15
EV/EBIT
31.01
EV/EBITDA
18.57
EV/Sales
4.13
The EPS has decreased by 44% YoY and by 9% from the previous quarter
The stock's price to book (P/B) is 40% less than its 5-year quarterly average of 4.8 and 20% less than its last 4 quarters average of 3.6
ATRI's P/S is 42% below its 5-year quarterly average of 7.2 and 19% below its last 4 quarters average of 5.1
ATRI's revenue is down by 8% year-on-year

Efficiency

How efficient is Atrion business performance
The ROIC has contracted by 48% YoY and by 7% from the previous quarter
ATRI's return on equity is down by 43% year-on-year and by 9% since the previous quarter
ATRI's return on assets is down by 43% year-on-year and by 9% since the previous quarter
The ROS has decreased by 40% YoY and by 6% from the previous quarter

Dividends

What is ATRI's dividend history
Dividend details
DPS
$8.75
Dividend yield
2.19%
Payout ratio
79.4%
Recent dividends

Financial health

How did Atrion financials performed over time
ATRI's current ratio is up by 38% year-on-year and by 20% since the previous quarter
The total liabilities has contracted by 29% YoY and by 27% from the previous quarter
Atrion's debt is 100% lower than its equity
The debt to equity has plunged by 100% from the previous quarter
Atrion's debt has shrunk by 100% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.